Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback